医学
辛伐他汀
门静脉压
门脉高压
肝硬化
内科学
安慰剂
奇静脉
随机对照试验
静脉曲张
胃肠病学
临床终点
肝功能
血流动力学
心脏病学
外科
病理
替代医学
作者
Priscila Pollo‐Flores,Mônica Soldan,Ubiratan Cassano Santos,Danielle Gobbi Kunz,Denise S. Mattos,Alexandre Cerqueira da Silva,Roberta Cabral Marchiori,Guilherme Rezende
标识
DOI:10.1016/j.dld.2015.07.156
摘要
Pleiotropic effects of statins decrease intrahepatic resistance and portal hypertension.We evaluated the effects of simvastatin on hepatic venous pressure gradient (HVPG) and azygos vein blood flow in cirrhotic patients.A 3-month prospective, randomized, triple-blind trial with simvastatin (40 mg/day) vs. placebo was conducted in patients with cirrhotic portal hypertension. HVPG and azygos blood flow, measured by colour Doppler endoscopic ultrasound, were assessed before and after treatment. The primary endpoint was a decrease in the HVPG of at least 20% from baseline or to ≤12 mmHg after the treatment.34 patients were prospectively enrolled, and 24 completed the protocol. In the simvastatin group 6/11 patients (55%) presented a clinically relevant decrease in the HVPG; no decrease was observed in the placebo group (p=0.036). Patients with medium/large oesophageal varices and previous variceal bleeding had a higher response rate to simvastatin. HVPG and azygos blood flow values were not correlated. No significant adverse events occurred.Simvastatin lowers portal pressure and may even improve liver function. The haemodynamic effect appears to be more evident in patients with severe portal hypertension.
科研通智能强力驱动
Strongly Powered by AbleSci AI